The Food and Drugs Authority (FDA) has advised the general public to be cautious when buying palm oil at the market because of persistent worries about adulteration.
This warning is given in view of the FDA’s ongoing efforts to combat the presence of dangerous compounds, particularly the infamous “Sudan Four” dye that has been found in several commercially available palm oil products.
Read Also: Sarkodie Heads to Supreme Court in Battle Against FDA
Customers’ health is seriously at risk from the presence of this industrial dye, which is prohibited from being used in food products because of its carcinogenic properties.
The Deputy Chief Executive Officer of the FDA, Roderick Daddey-Adjei, expressed serious concerns about the issue’s continued existence in spite of the Authority’s strict enforcement measures.
Although he admitted that the occurrence of contaminated palm oil has decreased, he underlined that even a tiny amount of contamination is still unacceptable.
A study by the FDA in October 2023 found that out of 306 samples of palm oil collected from markets nationwide, 70 contained the prohibited “Sudan Four Dye.”
The Greater Accra Region recorded the highest failure rate at 60.8 percent.
Read Also: FDA targets influencer selling men’s products
“Sudan Four Dye” has many health effects on the consumer, and it includes cancer, hives, severe allergies and migraine.
